newsfilter
← Latest News
GlobeNewswire·

Tevogen Complements Capital Access with Two-Year Extension to Loan Agreement

  • Tevogen Inc. extended its borrowing period under an amended loan agreement with The Patel Family, LLP from May 2027 to May 2029.
  • The amended facility permits borrowings of up to $28.6 million subject to specific terms & conditions.
  • The loan complements the company's existing ATM equity program established for up to $50 million in aggregate sales.
  • Share sales under the ATM program are not obligatory & are subject to market conditions & applicable requirements.
  • The loan agreement allows for repayment in either cash or shares based on applicable terms.
  • Additional details regarding the amendment are available in the Company's Form 8-K filed with the SEC.
  • Tevogen operates through three initiatives: Tevogen Bio, Tevogen.AI, & Tevogen Healthcare Services to improve medication affordability & access.
Company
Tevogen Inc.
Keywords
Nasdaq:TVGN, Tevogen Inc., Tevogen, Capital Discipline, Financial Sustainability